KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announces that nonclinical data on the immunologic mechanism of action of PV-10 will be presented at the Society of Surgical Oncology Annual Meeting, March 21-24, 2012, at the Orlando World Center Marriott in Orlando, Florida. The data, by Dr. Paul Toomey and colleagues of the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, will be presented in the melanoma poster session, time and location to be announced at a later date.
